Checks how scar depth after stomach tumor removal affects healing
Part of Cancer, Digestive system clinical trials.
This study looks at early stomach cancer treated with ESD, a procedure to remove the tumor through the stomach lining, and how the depth of the scar relates to healing. It may help doctors predict better outcomes and improve the procedure for suitable patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 74.
- You have early stomach cancer (T1a) found on scope or ultrasound.
- The tumor type and size fit: no ulcer with certain size limits, or with ulcer only if small enough.
- Doctors say you need no further treatment right now after diagnosis.
- No serious bleeding, holes in the stomach, or other emergencies right now.
- No major bleeding/low clotting problems or severe heart, liver, or kidney disease that would make ESD unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to check stomach growths: a special microscope test called pCLE and a standard tissue sample test. It aims to see which one finds problems more accurately before surgery.
This study tests whether adding sucralfate (a stomach-lining protectant) to the standard acid-reducer esomeprazole helps heal ulcers that form after a procedure called ESD for early stomach cancer. It helps find which combination works better for recovery.
This study compares two approaches after a non-curative ESD for early stomach cancer: one that removes sentinel lymph nodes (the first nodes where cancer might spread) and one that does not. Participating may help find out if removing these nodes improves outcomes.
This trial evaluates how useful a procedure called ESD is for patients as part of routine care. ESD is done during an endoscopy, and the study checks whether it works well and is helpful in the real world.
This study tests a new robot-assisted tool to remove early-stage stomach cancer or precancerous cells through a scope (endoscope) without open surgery. The goal is to see if it is safe and effective at removing the abnormal tissue completely.
This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.